CARDIONOVUM GmbH
Manel Martinez is currently the Vice President of Sales at CARDIONOVUM GmbH. Prior to this role, Manel held various leadership positions in companies such as Translumina Therapeutics, OrbusNeich, and IHT Iberhospitex- IHT Medical, with a focus on Interventional Cardiology. With a strong background in sales and marketing in the medical device industry, Manel has also served as the General Manager Hospital Division at Grupo Petrone and as the Country Manager Iberia at Abbott Vascular Devices. Manel holds a Master's degree in Sales & Marketing from IESE Business School and a Master's degree in Marketing from EADA Business School.
This person is not in the org chart
This person is not in any offices
CARDIONOVUM GmbH
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The company’s pioneering range of DCBs is based on the SAFEPAX® paclitaxel coating matrix which has the lowest wash-off rates on the market. The company’s strong commitment to clinical research ensures a continually deepening and expanding evidence-base in support of the clinical benefits of our products. Pioneers in medical devices. The worldwide first CE-approved DCB. With the first DCB market introduction, CARDIONOVUM contributed significantly to the establishment of a new medical device therapy to treat coronary and peripheral artery disease effectively. CARDIONOVUM consists of R & D staff, with the longest and most profound experience, in developing clinically advanced DCB and DES cardiovascular devices. “Live Deserves the Best”